Minister sees industry at US$14bn by 2022 The Indian medical technology industry would grow to US$14 billion by 2022 from the present level of US$1.4 billion, riding on the back of unprecedented digital initiatives and focus on manufacturing, particularly electronics equipment.
Industry grew at 17.46% CAGR in a decade Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances with a CAGR of 17.46% and market value of US$36.7 billion in 2016, says BizVibe.
Supratech to get DNA sequencing data technique. Saphetor SA, the Swiss precision-medicine company dedicated to advancing personalized diagnostics, will provide its proprietary platform for analyzing next-generation DNA sequencing data to Supratech Micropath of Ahmedabad, a reference and diagnostic lab with significant experience in clinical
NAM earmarks Rs.440 crore for medical facilities. The government has approved 39 hospitals, each of 50-bed, from 45 proposals received during 2016-17, said Minister of State for AYUSH (Independent Charge), Shripad Yesso Naik in reply to a question in Lok Sabha on 28 July 2017.
Govt grant provided to the State/UT Governments A total of 25 ‘50-bedded’ hospitals with an outlay of Rs.145 crore has been approved in the year 2016-17, the Rajya Sabha was told on 18 July 2017. Under Centrally Sponsored Scheme of National AYUSH Mission (NAM), there
Zip Surgical Skin Closure device for Indians. ZipLine® Medical, Inc., an innovator in skin closure, gets approval to enter the US$3.5 billion medical device market in India.
Electrolab partnership to help Simulations Plus in India. The Indian pharmaceutical market is expected to continue to enjoy robust growth as it has in the past 10 years, said a California-based executive.
TA invests in Ideal Cures #TA Associates, a leading global growth private equity firm, has completed an investment in India’s #Ideal Cures Private Limited, which has expansion plans in the healthcare sector.
Vyome gel for acne #Vyome Biosciences has announced on 7 Feb 2017 top-line data from its phase 1 clinical trial evaluating VB-1953, a topically administered gel designed to treat patients with moderate to severe acne.
Merck grant for ECHO #The Merck Foundation has provided a grant of US$7 million over five years to help improve health in India and Vietnam.